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Abstract
The proper regulation of apoptosis requires precise spatial and temporal control of gene expression. While the
transcriptional and translational activation of pro-apoptotic genes is known to be crucial to triggering apoptosis, how
different mechanisms cooperate to drive apoptosis is largely unexplored. Here we report that pro-apoptotic transcriptional
and translational regulators act in distinct pathways to promote programmed cell death. We show that the evolutionarily
conserved C. elegans translational regulators GCN-1 and ABCF-3 contribute to promoting the deaths of most somatic cells
during development. GCN-1 and ABCF-3 are not obviously involved in the physiological germ-cell deaths that occur during
oocyte maturation. By striking contrast, these proteins play an essential role in the deaths of germ cells in response to
ionizing irradiation. GCN-1 and ABCF-3 are similarly co-expressed in many somatic and germ cells and physically interact in
vivo, suggesting that GCN-1 and ABCF-3 function as members of a protein complex. GCN-1 and ABCF-3 are required for the
basal level of phosphorylation of eukaryotic initiation factor 2a (eIF2a), an evolutionarily conserved regulator of mRNA
translation. The S. cerevisiae homologs of GCN-1 and ABCF-3, which are known to control eIF2a phosphorylation, can
substitute for the worm proteins in promoting somatic cell deaths in C. elegans. We conclude that GCN-1 and ABCF-3 likely
control translational initiation in C. elegans. GCN-1 and ABCF-3 act independently of the anti-apoptotic BCL-2 homolog CED-
9 and of transcriptional regulators that upregulate the pro-apoptotic BH3-only gene egl-1. Our results suggest that GCN-1
and ABCF-3 function in a pathway distinct from the canonical CED-9-regulated cell-death execution pathway. We propose
that the translational regulators GCN-1 and ABCF-3 maternally contribute to general apoptosis in C. elegans via a novel
pathway and that the function of GCN-1 and ABCF-3 in apoptosis might be evolutionarily conserved.
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Introduction
Apoptosis is a naturally occurring process that eliminates
unwanted cells during development and maintains tissue homeo-
stasis [1,2]. For example, apoptosis removes most larval tissues of
insects during metamorphosis, sculpts the future inner ear in
chicks, eliminates the interdigital web in mammals and shapes the
endocardial cushion into valves and septa to generate the four-
chamber architecture of the mammalian heart [1,2]. Apoptosis
also culls nearly 80% of oocytes prior to birth in humans and
eliminates cells that receive insufficient cell-survival signals to
maintain homeostasis [1]. The improper regulation of an
apoptotic program can result in either too much or too little cell
death, leading to developmental abnormalities and a wide variety
of human disorders, such as cancer, neurodegenerative diseases,
autoimmune diseases and developmental disorders [3,4]. It is
important to identify mechanisms that regulate apoptosis to
understand both animal development and human disorders caused
by the dysregulation of apoptosis.
The precise spatial and temporal expression of regulators of
apoptosis is known to be crucial for initiating the apoptotic cell-
killing program during development and in response to environ-
mental stresses, including ionizing radiation, temperature change,
nutrient limitation, oxidative stress and viral infection [1,2]. Many
examples of the transcriptional control of apoptosis have been
described. For example, in mammals the genes that encode the
pro-apoptotic BCL-2 family member BAX, the BH3-only proteins
NOXA, PUMA and BID, the apoptotic protease-activating factor-
1 APAF-1 and the death receptor 5 DR5 protein are transcrip-
tionally upregulated by the tumor suppressor p53 transcription
factor in response to DNA damage or to the induced expression of
p53 [5–11], resulting in an induction of apoptosis. The Drosophila
apoptotic activator gene reaper is upregulated by multiple
transcriptional regulators, including Hox transcription factors,
nuclear hormone receptors, AP-1, Polycomb, p53, and histone-
modifying enzymes, to promote the morphogenesis of segment
boundaries, metamorphosis, and DNA damage responses [1]. In
C. elegans, the transcription of the pro-apoptotic BH3-only gene
egl-1 is directly regulated in a cell-specific manner by transcription
factors that include the Hox family proteins MAB-5, CEH-20,
LIN-39 and CEH-34, the E2F protein EFL-3, the Snail family
zinc finger protein CES-1, the Gli family transcription factor
TRA-1, and the basic helix-loop-helix proteins HLH-2 and HLH-
3 [12–15]. The caspase gene ced-3 is also upregulated by the Hox
transcription factor PAL-1 in the tail spike cell before its death
[16]. Recently, we showed that the Sp1 transcription factor SPTF-
3 directly drives the transcription of both the pro-apoptotic BH3-
only gene egl-1, which mediates a caspase-dependent apoptotic
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pathway, and the AMPK-related gene pig-1, which mediates a
caspase-independent apoptotic pathway [17]. The transcriptional
regulation of apoptotic genes clearly plays a crucial role in
determining whether specific cells live or die during development.
Translational control is also important for the apoptotic process.
In mammals, expression of the pro-apoptotic protein APAF-1 and
the anti-apoptotic protein X-chromosome-linked inhibitor of
apoptosis XIAP are regulated at the translational level by internal
ribosome-entry sites (IRES) [18]. Exposure of cultured mamma-
lian cells to etoposide or UV light induces APAF-1 expression via
IRES-mediated translation, resulting in the activation of the
caspase-dependent apoptotic program [19]. The protein level of
XIAP is increased via IRES-mediated translation under stress
conditions, such as serum starvation [20]. However, the specific
translational regulators involved in IRES-mediated translation of
APAF-1 and XIAP are unknown. In C. elegans, the RNA-binding
protein GLD-1, which is highly expressed in the transition zone
and early pachytene regions of the hermaphrodite gonad, inhibits
translation of the mRNA of the p53 homolog cep-1 by directly
binding to the cep-1 39 UTR, thereby preventing cep-1-dependent
apoptosis in response to DNA damage [21]. Translational
initiation factors have also been reported to be involved in the
control of apoptosis in C. elegans. For example, RNAi knockdown
of the C. elegans eukaryotic initiation factor-4G IFG-1 induces
CED-4 expression in the gonad and increases the frequency of
germ-cell death [22,23]. The eukaryotic initiation factor-3
subunit-k eIF-3.K is partially required for the deaths of somatic
cells and acts through the caspase CED-3 to promote those cell
deaths [24]. Although many studies have shown that both
transcriptional and translational regulation of apoptotic genes is
crucial for controlling apoptotic programs, how transcriptional
and translational mechanisms are coordinated to promote
apoptosis remains elusive.
Here we show that the maternally-contributed translational
regulators GCN-1 and ABCF-3 act together to promote the cell
deaths of possibly all somatic cells and of germ cells in response to
ionizing radiation in a pathway distinct from the BCL-2 homolog
CED-9-regulated canonical cell-death execution pathway of C.
elegans. GCN-1 and ABCF-3 are required to maintain the basal
level of phosphorylation of eukaryotic initiation factor 2 (eIF2a).
The functions of GCN-1 and ABCF-3 in the promotion of
programmed cell death are evolutionarily conserved between C.
elegans and Saccharomyces cerevisiae. We show that GCN-1 and
ABCF-3 cooperate with the transcriptional regulators CEH-34,
EYA-1 and SPTF-3 and the protein kinase PIG-1 to promote the
death of a specific somatic cell, the sister cell of the pharyngeal M4
motor neuron. We propose that the evolutionarily-conserved
translational regulators GCN-1 and ABCF-3 contribute to
apoptosis in general.
Results
The translational regulators GCN-1 and ABCF-3 are
required for M4 sister cell death
The C. elegans pharyngeal M4 motor neuron is generated
during embryonic development and survives to regulate pharyn-
geal muscle contraction in feeding behavior, whereas the M4 sister
cell dies by programmed cell death soon after its generation
(Figure 1A) [25,26]. We created a Pceh-28::gfp reporter transgene
that expresses GFP specifically in the M4 neuron of wild-type
animals and in both the M4 neuron and the surviving M4 sister of
ced-3 caspase mutants defective in programmed cell death
(Figure 1B–1C). This reporter allowed us to easily identify mutants
with a defect in M4 sister cell death. [15]. Using this reporter, we
performed a genetic screen for mutations that cause a defect in M4
sister cell death. Among our isolates were two non-allelic
mutations, n4827 and n4927, that caused M4 sister survival in
12% of n4827 mutants and 13% of n4927 mutants (Figure 1D–
1F).
We mapped n4827 to a 175 kb interval of chromosome III
containing 18 predicted genes (Figure S1A). We used whole-
genome sequencing to identify four strain-specific unique homo-
zygous mutations within this interval in n4827 animals (Figure
S1A) [27]. Of the four mutations, only one was exonic. This
mutation was located in the third exon of gcn-1, which encodes a
homolog of the S. cerevisiae Gcn1p protein. The n4827 mutation
is predicted to change the tryptophan 164 codon to an opal stop
codon, generating a small truncated protein (Figure 1G). A
deletion mutation of gcn-1, nc40D, phenocopied the n4827
mutation [28]: 11% of gcn-1(nc40D) mutants and 12% of n4827
mutants had a surviving M4 sister, respectively (Figure 1F). The
cell-death defect of n4827 mutants was partially rescued by a
transgene that express gcn-1 cDNA under the control of the gcn-1
promoter (Figure 1F). These results indicate that n4827 is likely a
null allele of gcn-1 and that loss of gcn-1 function causes a defect
in M4 sister cell death.
We mapped n4927 to a 5.3 Mb interval of chromosome III
(Figure S1B). This interval contains the gene abcf-3, which
encodes a homolog of the S. cerevisiae Gcn20p protein [29].
Gcn20p physically interacts with Gcn1p, the S. cerevisiae homolog
of GCN-1 [30]. We determined the sequence of abcf-3 in n4927
animals and identified a mutation that changes the arginine 206
codon to an opal stop codon (Figure 1G). A deletion mutation of
abcf-3, ok2237D, that removes most of the abcf-3 coding region
phenocopied the n4927 mutation: 13% of abcf-3(ok2237D)
mutants and 13% of n4927 mutants had a surviving M4 sister
(Figure 1F). Furthermore, the cell-death defect of n4927 mutants
was completely rescued by a transgene carrying only the abcf-3
genomic locus. We concluded that n4927 is likely a null allele of
abcf-3 and that loss of abcf-3 function causes a defect in M4 sister
cell death.
abcf-3 encodes an AAA ATPase protein with two AAA domains
(Figure 1G). In many proteins AAA domains have ATPase
Author Summary
Apoptosis, also referred to as programmed cell death, is a
crucial cellular process that eliminates unwanted cells
during animal development and tissue homeostasis.
Abnormal regulation of apoptosis can cause developmen-
tal defects and a variety of other human disorders,
including cancer, neurodegenerative diseases and autoim-
mune diseases. Therefore, it is important to identify
regulatory mechanisms that control apoptosis. Previous
studies have demonstrated that the transcriptional induc-
tion of apoptotic genes can be crucial to initiating an
apoptotic program. Less is known about translational
controls of apoptosis. Here we report that the evolution-
arily conserved C. elegans translational regulators GCN-1
and ABCF-3 promote apoptosis generally and act inde-
pendently of the anti-apoptotic BCL-2 homolog CED-9.
GCN-1 and ABCF-3 physically interact and maintain the
phosphorylation level of eukaryotic initiation factor 2a,
suggesting that GCN-1 and ABCF-3 act together to
regulate the initiation of translation. We propose that the
translational regulators GCN-1 and ABCF-3 maternally
contribute to the proper execution of the apoptotic
program.
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activity. To determine whether ATPase activity is important for
ABCF-3 to promote M4 sister cell death, we generated abcf-3
transgenes carrying mutations that presumably inactivate the
ATPase activity of each AAA domain by altering the lysine
residues known to be catalytically essential for other AAA ATPases
[31]. A wild-type abcf-3 transgene as well as mutant abcf-3
transgenes that changed lysine 217 of the first AAA domain to
methionine [abcf-3 (K217M)], lysine 536 of the second AAA
domain to methionine [abcf-3 (K536M)] or both lysine residues
[abcf-3 (K217M, K536M)] completely rescued the defect in M4
sister cell death of abcf-3(n4927) mutants (Figure 1F). These
results support the idea that the ATPase activity of ABCF-3 is
dispensable for M4 sister cell death. This result is consistent with
studies of S. cerevisiae Gcn20p, the homolog of C. elegans ABCF-
3. Gcn20p that lacks the ATPase activities of both AAA domains
because of mutations in conserved glycine residues (Gly371 and
Gly654) or because of the deletion of two AAA domains still
retains Gcn20p function comparable to that of wild-type Gcn20p
[32].
GCN-1 and ABCF-3 act together to promote M4 sister cell
death
GCN-1 and ABCF-3 are evolutionarily conserved among S.
cerevisiae, C. elegans and humans (Figure 1H, Figure S2 and S3).
Expression of S. cerevisiae GCN1, the homolog of C. elegans gcn-
1, and GCN20, the homolog of C. elegans abcf-3, under the
control of the abcf-3 promoter rescued the defect in M4 sister cell
death of C. elegans gcn-1 and abcf-3 mutants, respectively,
indicating that S. cerevisiae GCN1 and GCN20 are functional
homologs of C. elegans gcn-1 and abcf-3, respectively (Figure 1F).
S. cerevisiae Gcn1p has a domain (amino acids 1350–2152)
similar to that of translation elongation factor 3 (EF3). The EF3-
like domain is highly conserved among species (Figure 1H and
Figure S2) and is necessary and sufficient for binding to Gcn20p
[32]. We therefore tested whether C. elegans GCN-1 can
physically interact with ABCF-3 using the yeast two-hybrid assay
(Figure 2A). Full-length GCN-1 (1–2634) interacted with full-
length ABCF-3 (1–712). To identify the protein domains
important for GCN-1 to bind to ABCF-3, we generated a series
Figure 1. gcn-1(n4827) and abcf-3(n4927) cause a defect in M4 sister cell death. (A) Schematic representation of the M4 cell lineage in the
wild type and mutants defective in M4 sister cell death. X, programmed cell death. (B–E) Merged epifluorescence and Nomarski images of the
pharynx in wild-type, ced-3(n717), gcn-1(n4827) and abcf-3(n4927) animals expressing Pceh-28::gfp. Arrow, M4 neuron. Arrowhead, surviving M4 sister.
Scale bar, 20 mm. Panels B and C from ref. 15. (F) The percentages of M4 sister survival in animals of the indicated genotypes. (G) Genomic
organizations and protein structures of gcn-1 and abcf-3, including the locations and natures of the mutations n4827 and n4927. Orange box, EF3-like
domain. Green boxes, AAA domains. Black bars, sequences deleted in alleles gcn-1(nc40D) and abcf-3(ok2237D). (H) Comparison of amino acid
sequences of the entire protein or the EF3-like domain of GCN-1 and of the entire protein, the N-terminal domain, the first AAA domain or the second
AAA domain of ABCF-3 among yeast, C. elegans and humans. Clustal W was used to align amino-acid sequences and to calculate identity and
similarity.
doi:10.1371/journal.pgen.1004512.g001
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of deletion constructs of GCN-1 and assayed each for ABCF-3-
binding activity using the yeast two-hybrid assay. GCN-1
fragments not containing entire the EF3 domain (1–1760, 1–
880, 880–1760 and 1760–2634) or containing only the EF3
domain (1350–2150) failed to bind ABCF-3, whereas GCN-1
fragments containing the EF-3 domain and surrounding regions
(880–2634) bound ABCF-3. These results suggest that GCN-1
physically interacts with ABCF-3 but that unlike in yeast the EF3-
like domain is not sufficient for GCN-1 to bind to ABCF-3.
We also defined the domains of ABCF-3 important for ABCF-3
to bind to GCN-1 (Figure 2A). ABCF-3 fragments lacking the N-
terminal region (202–712, 512–712 and 202–512) failed to bind
GCN-1, whereas ABCF-3 fragments containing the N-terminal
region (1–712, 1–512 and 1–202) bound GCN-1, suggesting that
the N-terminal portion of ABCF-3 (which does not include the first
AAA domain) is necessary and sufficient for binding to GCN-1,
just as the N-terminal region of S. cerevisiae Gcn20p is necessary
and sufficient for binding to Gcn1p, the S. cerevisiae homolog of
GCN-1.
To determine whether GCN-1 and ABCF-3 interact in vivo, we
generated antibodies against GCN-1 and ABCF-3 and performed
co-immunoprecipitation experiments. We first tested whether
these antibodies specifically recognize GCN-1 or ABCF-3 protein
using western blot analysis. The antibodies against GCN-1 or
ABCF-3 recognized proteins of the sizes predicted for the GCN-1
or ABCF-3 proteins in wild-type animals but not in gcn-1(n4827)
or abcf-3(n4927) animals, respectively, confirming the specificity
of these antibodies (Figure 2C). Then we tested whether GCN-1
could be co-immunoprecipitated with ABCF-3. Whole-protein
extracts from wild-type animals were subjected to immunoprecip-
itation using an anti-ABCF-3 antibody (or normal IgG as a
control), and then immunocomplexes were analyzed by western
blotting using antibodies against ABCF-3 or GCN-1. Both ABCF-
3 and GCN-1 were recovered in an immunocomplex purified with
Figure 2. GCN-1 and ABCF-3 proteins are evolutionarily conserved functionally. (A) Schematic representations of the GCN-1 and ABCF-3
proteins used in the yeast two-hybrid binding assays. Orange box, EF3-like domain. Green boxes, AAA domains. The growth of yeast on histidine-
minus medium is summarized. +, wild-type growth. 2, no or little growth. (B) Western blot analysis of immunocomplexes purified from wild-type
animals with an anti-ABCF-3 antibody or control IgG. Both ABCF-3 and GCN-1 are present in the immunocomplex purified with an anti-ABCF-3
antibody but not with the control IgG. (C) Western blot analysis showing levels of ABCF-3 and GCN-1 proteins in fourth-larval stage animals of the
indicated genotypes. (D) Western blot analysis showing the levels of eIF2a with phosphorylated serine 49 and total eIF2a of fourth-larval stage
animals of the indicated genotypes. (E) Relative intensities of phosphorylated eIF2 to total eIF2 of fourth-larval stage animals of the indicated
genotypes. Errors, standard deviations.
doi:10.1371/journal.pgen.1004512.g002
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the anti-ABCF-3 antibody, whereas neither ABCF-3 nor GCN-1
was recovered in an immunocomplex purified with normal IgG
(Figure 2B). We conclude that GCN-1 and ABCF-3 are present in
the same protein complex in vivo.
Since GCN-1 and ABCF-3 form a complex in vivo, we
suspected that deletion of either protein might affect the stability of
the other protein [29,33]. To test this hypothesis, we examined the
levels of GCN-1 and ABCF-3 proteins by western blot analyses of
whole-protein extracts prepared from wild-type, gcn-1(n4827)
and abcf-3(n4927) animals using antibodies against ABCF-3 or
GCN-1. The steady-state level of ABCF-3 protein was decreased
in gcn-1(n4827) animals by 3.6 fold compared to that of wild-type
animals. Similarly, the steady-state level of GCN-1 protein was
decreased in abcf-3(n4927) animals by 4.4 fold (Figure 2C). These
results suggest that a lack of ABCF-3 or GCN-1 protein affects the
stability of the other protein and support our conclusion that
GCN-1 and ABCF-3 are in a protein complex together in vivo.
If GCN-1 and ABCF-3 physically interact in vivo to promote
M4 sister cell death, GCN-1 and ABCF-3 should act together in
the same pathway. Since gcn-1(n4827) and abcf-3(n4927) are
likely null mutations, the gcn-1(n4827) mutation would not
enhance the M4 sister cell-death defect of abcf-3(n4927) mutants
if gcn-1 and abcf-3 function in the same process or pathway.
Indeed, we observed no enhancement of the M4 sister cell-death
defect of gcn-1(n4827) abcf-3(n4927) double mutants compared
to that of either single mutant: there was 13% M4 sister survival in
gcn-1(n4827) abcf-3(n4927) double mutants, 12% M4 sister
survival in gcn-1(n4827) mutants and 13% M4 sister survival in
abcf-3(n4927) mutants (Figure 1F). We conclude that gcn-1 and
abcf-3 function together in the same process of pathway to
promote M4 sister cell death, consistent with our finding that
GCN-1 and ABCF-3 physically interact in vivo.
In S. cerevisiae, Gcn1p and Gcn20p are required for the
efficient phosphorylation of eukaryotic initiation factor 2 (eIF2a)
under both normal conditions and conditions of amino-acid
starvation [29,30]. Gcn1p and Gcn20p form a protein complex
that activates the serine-threonine protein kinase Gcn2p, which
then phosphorylates an evolutionarily conserved serine residue of
eIF2a. The amino acid sequences surrounding the eIF2a
phosphorylation site are identical in S. cerevisiae, C. elegans and
humans, suggesting a conserved regulatory mechanism of eIF2a
[28]. We tested whether GCN-1 and ABCF-3 promote the
phosphorylation of eIF2a in C. elegans using an antibody that
specifically recognizes eIF2a that is phosphorylated at serine 49 (P-
eIF2a). From wild-type animals cultivated under normal physio-
logical conditions, a single band of eIF2a was detected in western
blotting analyses using either the anti-P-eIF2a antibody or an
antibody that recognized total eIF2a (Figure 2D). In gcn-
1(n4827) and abcf-3(n4927) mutants, the phosphorylation levels
of eIF2a in physiological conditions were 52% and 54% of the
levels in wild-type animals, respectively (Figure 2D and 2E). We
conclude that gcn-1 and abcf-3 are required to maintain the
steady-state level of the phosphorylation of eIF2a.
The regulation of phosphorylation of eIF2a plays an essential
role in the initiation of translation. We therefore directly tested
whether gcn-1 and abcf-3 affect gene expression at the transla-
tional level. Since gcn-1 and abcf-3 are highly expressed in the
gonads at the fourth larval stage, maternally contribute to the
death of the M4 sister and affect most programmed cell deaths (see
below, Figure 3D and 3I, Table 1 and Table S5), we isolated both
wild-type animals and gcn-1 and abcf-3 mutants at the fourth
larval stage and performed mRNA-seq and ribosome profiling
(Ribo-seq) to generate quantitative genome-wide information
concerning mRNA abundance and the locations of mRNAs
occupied by ribosomes [34]. Parallel analyses of data from Ribo-
seq and mRNA-seq studies allowed us to distinguish differences in
mRNA abundance from differences in translational control and to
generate a quantitative and comprehensive list of genes the
expression of which is likely regulated by gcn-1 and abcf-3 at the
translational level. Loss of gcn-1 or abcf-3 function affected the
expression of a large number of genes at either the transcriptional
or translational level or at both (Figure S4A and S4B and Table
S1). Since GCN-1 and ABCF-3 very likely function in translational
control, their effects on transcript levels are likely indirect.
Changes in gene expression compared to wild-type animals were
similar between gcn-1 and abcf-3 mutants, supporting our
conclusion that gcn-1 and abcf-3 act together (Figure S4C and
S4D). The expression of 464 genes or 217 genes changed in both
gcn-1 and abcf-3 mutants compared to wild-type animals at least
two-fold (p,0.1) in mRNA-seq or Ribo-seq analyses, respectively
(Figure S4E and S4F). Of the 217 genes altered in translational
expression, 98 genes showed no alterations in mRNA levels using
our standards of a two-fold change and p,0.1 (Table S2 and
Table S3). These genes are candidates for being directly regulated
by both gcn-1 and abcf-3 translationally. These results suggest that
gcn-1 and abcf-3 function together in the translational control of
many genes.
In mammals, eIF2a phosphorylation is mediated by at least four
different protein kinases: PKR-like endoplasmic reticulum kinase
(PERK), general control non-derepresessible-2 (GCN2), double-
stranded RNA-activated protein kinase (PKR) and heme-regulated
Figure 3. gcn-1 and abcf-3 are ubiquitously expressed. (A–E)
Expression pattern of gcn-1. (A–C) Expression of GFP under the control
of the gcn-1 promoter in second-larval stage animals and (D and E) FISH
of gcn-1 mRNA in third-larval stage animals. Green, gcn-1 mRNA. Blue,
DAPI staining of nuclei. (F–J) Expression pattern of abcf-3. (F–H)
Expression of GFP under the control of the abcf-3 promoter in the
second-larval stage animals and (I and J) FISH of abcf-3 mRNA in third-
larval stage animals. Green, abcf-1 mRNA. Blue, DAPI staining of nuclei.
Arrows, M4 neuron. Arrowheads, intestinal cells. Scale bars, 50 mm in A
and F; 10 mm in B, C, G, H; and 5 mm in D, E, I and J.
doi:10.1371/journal.pgen.1004512.g003
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inhibitor kinase (HRI); each of these kinases is activated by a
distinct stress signal [18]. These kinases share homology in their
kinase catalytic domains, but their effector domains are distinct
and are subject to different regulatory mechanisms. Homologs of
genes encoding two of these protein kinases exist in the C. elegans
genome: the PERK homolog PEK-1 and the GCN2 homolog
GCN-2. Y38E10A.8 has a kinase domain similar to that of
mammalian eIF2a kinases but does not have an obvious homolog.
We tested whether these three protein kinases are required for the
programmed cell death of the M4 sister. Neither single mutants of
each kinase gene nor the triple mutant was defective in M4 sister
cell death (Table S4), suggesting that one or more unidentified
protein kinase(s) regulated by GCN-1 and ABCF-3 are responsible
for phosphorylating eIF2a in the regulation of M4 sister cell death.
Alternatively, it is possible GCN-1 and ABCF-3 promote M4 sister
cell death through one or more targets other than eIF2a.
gcn-1 and abcf-3 are expressed ubiquitously
To determine the expression patterns of gcn-1 and abcf-3, we
generated transgenes expressing a reporter GFP under the control
of the endogenous gcn-1 or abcf-3 promoter. Both gcn-1 and abcf-
3 were expressed in most cells during all stages of development.
We observed gcn-1 and abcf-3 expression in head neurons,
hypodermal cells, intestinal cells, body wall muscles, and
pharyngeal neurons, including the M4 neuron (Figure 3A–3C
and 3F–3H). We also used the technique of fluorescence in situ
hybridization (FISH) with a level of sensitivity sufficient to detect
single mRNA molecules [35] to observe endogenous gcn-1 and
abcf-3 transcripts. Consistent with the expression of the GFP
reporter transgenes, gcn-1 and abcf-3 mRNAs were observed in
most somatic cells. In addition, gcn-1 and abcf-3 mRNAs were
abundant in the germ cells in the hermaphrodite gonad
(Figure 3D, 3E, 3I and 3J). The similar expression patterns of
gcn-1 and abcf-3 are consistent with our observations that GCN-1
and ABCF-3 physically interact and act together to promote the
death of the M4 sister.
Since gcn-1 and abcf-3 are ubiquitously expressed and required
to broadly maintain the basal level of phosphorylation of eIF2a,
we tested whether gcn-1 and abcf-3 might be involved in other
biological processes. We did not observe abnormalities in the
morphologies of the hermaphrodite vulva, the male tail or
the neurite processes of the M4, I2 and PVQ neurons. However,
the growth rate of gcn-1 and abcf-3 mutants from embryogenesis
to the fourth larval stage was around 24 hours longer than that of
wild-type animals, and the mitotic pachytene region of the
hermaphrodite gonad was expanded over the loop regions of the
gonads. (data not shown). These observations suggest that gcn-1
and abcf-3 affect biological processes in addition to programmed
cell death.
GCN-1 and ABCF-3 promote the deaths of most somatic
cells during development and of germ cells in response
to ionizing radiation
Given the ubiquitous expression patterns of gcn-1 and abcf-3,
we tested whether gcn-1 and abcf-3 promote programmed cell
deaths in addition to that of the M4 sister. We examined gcn-
1(n4827) and abcf-3(n4927) mutants for defects in the deaths of
the NSM sisters, the PVQ sisters, the g1A sisters, the RIM and
RIC sisters and multiple cells in the anterior pharynx. gcn-
1(n4827) and abcf-3(n4927) single mutants did not exhibit
defects in the deaths of these cells (Table 1). However, when either
the gcn-1(n4827) or the abcf-3(n4927) mutation was combined
with the partial loss-of-function ced-3(n2427) mutation, which
sensitizes strains to weak defects in cell death [36], we observed
significant cell-death defects for all cell types tested (Table 1). For
example, the gcn-1(n4827) and abcf-3(n4927) mutations en-
hanced the ced-3(n2427) defect from 16% to 38% and 34%,
respectively, for the NSM sister and from 13% to 36% and 45%,
respectively, for the g1A sister. We conclude that gcn-1 and abcf-3
promote programmed cell death generally rather than specifically
affecting the M4 sister cell death.
We next tested whether gcn-1 and abcf-3 are involved in the
deaths of germ cells in the gonad of the adult hermaphrodite.
More than half of germ cells stochastically undergo programmed
cell death under normal conditions during oocyte differentiation
[37]. We scored the number of apoptotic germ cells using the vital
dye acridine orange (AO), which stains nucleic acids within
apoptotic cells in living animals [38]. gcn-1(n4827) and abcf-
3(n4927) mutants had 9.1 and 9.5 apoptotic germ cells per
gonadal arm on average, respectively, similar to wild-type animals,
which had 8.6 apoptotic germ cells per gonadal arm (Figure 4I).
We also scored the number of apoptotic germ cells by direct
observation of the gonads of engulfment-defective ced-1(e1735)
mutants, in which cell corpses accumulate because of a defect in
Table 1. gcn-1(n4827) and abcf-3(n4927) enhance the cell-death defects of partial loss-of-function ced-3(n2427) mutants.
Genotype M4 sister NSM sisters PVQ sisters g1A sisters
RIM and RIC
sisters
Extra cells±SD (anterior
pharynx)
Wild-type 0 0 0 0 0 0.060.0
gcn-1(n4827) 12 0 11 11 01 0.160.3
abcf-3(n4927) 13 0 12 12 02 0.160.3
ced-3(n2427) 48 16 4 13 23 1.460.9
gcn-1(n4827); ced-3(n2427) 98 38 161 361 44 3.761.13
abcf-3(n4927); ced-3(n2427) 94 34 142 452 46 3.861.33
The percentages of the survival of the M4 sister, NSM sisters, PVQ sisters, g1A sisters and RIM and RIC sisters or numbers of extra cells in the anterior pharynx.
More than 100 cells were scored for survival of the M4 sister, NSM sisters, PVQ sisters, g1A sisters and RIM and RIC sisters.
24 animals were scored for extra cells in the anterior pharynx.
All strains were homozygous for the reporter transgene to score survival of the indicated cells except for the extra cells in the anterior pharynx. See Materials and
Methods for the reporter transgenes.
1These strains were homozygous for unc-45(r450).
2These strains were homozygous for dpy-18(e364).
3Student’s t-test compared with ced-3(n2427), P,0.0001.
doi:10.1371/journal.pgen.1004512.t001
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cell-corpse engulfment, facilitating a sensitive assay for the deaths
of germ cells [37]. ced-1(e1735) mutants had an average of 14.4
cell corpses per gonadal arm (Figure S5). ced-1(e1735) double
mutants with gcn-1(n4827) or abcf-3(n4927) had nearly identical
numbers of cell corpses per gonadal arm, 13.9 and 14.0,
respectively (Figure S5). These results indicate that gcn-1 and
abcf-3 are dispensable for germ-cell death under physiological
conditions.
Since many germ cells undergo apoptosis in response to
genotoxic stresses such as ionizing radiation [39], we tested
whether gcn-1 and abcf-3 mediate ionizing radiation damage-
induced germ cell death. As assayed with AO, wild-type
animals normally contained an average of 8.6 apoptotic germ
cells per gonadal arm, while wild-type animals exposed to
ionizing radiation contained on average 27.1 apoptotic germ
cells (Figure 4A, 4E and 4I). This germ-cell death was
completely blocked by a mutation in the caspase gene ced-3
in wild-type, gcn-1(n4837) and abcf-3(n4927) animals
(Figure 4B, 4F and 4I). Strikingly, ionizing radiation failed to
increase the number of apoptotic germ cells in gcn-1(n4827)
and abcf-3(n4927) mutants (10.9 and 10.4 apoptotic germ
cells per gonadal arm in gcn-1 and abcf-3 mutants, respec-
tively, 24 hours after gamma ray irradiation) (Figure 4C, 4D,
4G, 4H and 4I). These results indicate that gcn-1 and abcf-3
are required for ionizing radiation-induced germ cell death but
not for the stochastic germ cell death that occurs in
physiological conditions.
gcn-1 and abcf-3 gene dosage affects programmed cell
death
The gcn-1(n4827) and abcf-3(n4927) mutations partially
blocked both the programmed cell deaths of somatic cells
(Table 1) and the deaths of germ cells in response to ionizing
radiation (Figure 4). Both somatic and ionizing radiation-induced
germ cell deaths involve the canonical cell-death execution
pathway consisting of the BH3-only gene egl-1, the BCL-2
homolog ced-9, the pro-apoptotic APAF-1 homolog ced-4, and
the caspase gene ced-3 [40]. Interestingly, animals doubly
heterozygous for gcn-1 and ced-3, ced-4 or egl-1 had a defect in
M4 sister cell death (gcn-1/+; ced-3/+ 18%, gcn-1/+; ced-4/+ 12%
or gcn-1/+; egl-1/+ 17%, respectively) significantly higher than
that of singly heterozygous animals (gcn-1/+ 4%, ced-3/+ 0%, ced-
4/+ 0% or egl-1/+ 1%, respectively) (Table S5). These results
indicate that the simultaneous reduction by half of the dosage of
gcn-1 and of genes in the canonical cell-death execution pathway
causes a significant defect in M4 sister cell death. We observed a
similar genetic interaction in animals heterozygous for abcf-3 and
ced-3, ced-4 or egl-1 (Table S5).
gcn-1 and abcf-3 maternally contribute to programmed
cell death
We observed that maternal gcn-1 and abcf-3 contribute to
zygotic programmed cell death. While gcn-1(2) animals gener-
ated by gcn-1(2) hermaphrodites and gcn-1(2) males exhibited a
defect in M4 sister cell death (12% of M4 sister survival), gcn-1(2)
Figure 4. gcn-1(n4827) and abcf-3(n4927) cause a defect in radiation-induced germline cell death. (A–D) Acridine orange (AO) staining of
apoptotic germ cells in the posterior gonads of animals of the indicated genotypes. Arrowheads, AO-positive apoptotic germ cells. Scale bar, 10 mm.
(E–H) Nomarski DIC images corresponding to A–D. Arrowheads, refractile apoptotic cells. (I) Numbers of AO-positive apoptotic germ cells in the
posterior gonads of animals of the indicated genotypes. White bars, means and standard errors of the means without ionizing radiation (IR). Black
bars, means and standard errors of the means with IR.
doi:10.1371/journal.pgen.1004512.g004
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animals produced from gcn-1/+ hermaphrodites and gcn-1(2)
males did not (0% of M4 sister survival) (Table S5), indicating that
maternal gcn-1 is sufficient to promote programmed cell death.
gcn-1(2) animals generated by gcn-1(2) hermaphrodites and
gcn-1/+ males exhibited a defect in M4 sister cell death (13% of
M4 sister survival). gcn-1/+ animals generated by gcn-1(2)
hermaphrodites and gcn-1(+) males exhibited a very weak defect
in M4 sister cell death (4% of M4 sister survival) compared to 12%
of M4 sister survival in gcn-1(2) self-progeny of gcn-1(2)
hermaphrodites. By contrast, gcn-1/+ animals produced from
gcn-1(+) hermaphrodites and gcn-1(2) males exhibited no defect
in M4 sister cell death (0% of M4 sister survival) (Table S5). These
results indicate that maternal gcn-1 is partially required for the M4
sister to undergo programmed cell death. We observed a similar
maternal requirement and sufficiency for abcf-3 (Table S5). We
conclude that maternal gcn-1 and abcf-3 are sufficient and
partially required for the M4 sister to undergo programmed cell
death.
GCN-1 and ABCF-3 act independently of the BCL-2
homolog CED-9 to promote programmed cell death and
can act in the cell fated to die
To examine interactions between gcn-1 and abcf-3 and the
canonical cell-death execution pathway, we performed epistasis
analyses between gcn-1 or abcf-3 and ced-9, which functions
downstream of egl-1 and upstream of ced-4 and ced-3 in the cell-
death execution pathway [40]. Because the ced-9(n2812) null
mutation causes ectopic cell deaths and organismic inviability, we
used the ced-3 partial loss-of-function mutation n2446 to suppress
ced-9(n2812) lethality [41]. We observed that 50% of ced-
9(n2812) animals had a surviving M4 sister in the ced-3(n2446)
mutant background. This increase over the 5% frequency of M4
sister survival in ced-3(n2446) mutants is consistent with the
proposal that ced-9 has a cell-killing activity [42]. We observed
that gcn-1 ced-9 and abcf-3 ced-9 double mutants were more
highly penetrant for M4 sister survival (90% and 89%, respec-
tively) than either single mutant in the ced-3(n2446) mutant
background: gcn-1 (45%), abcf-3 (40%) and ced-9 (50%),
respectively (Table 2). These results indicate that ced-9 is not
required for gcn-1 and abcf-3 to promote programmed cell death.
Thus, gcn-1 and abcf-3 function downstream of or in parallel to
ced-9 in the regulation of programmed cell death.
We next tested whether the activity of gcn-1 and abcf-3 can act
cell-autonomously to promote programmed cell death. Previous
studies showed that expression of a ced-3, ced-4 or egl-1 cDNA
under the control of the mec-7 promoter can act cell-autono-
mously to cause the deaths of a set of touch neurons, including the
PLML and PLMR cells. We expressed gcn-1 and abcf-3 cDNAs in
the PLM neurons under the control of the mec-7 promoter. We
observed that 100% of the PLM neurons survived in wild-type
animals, whereas only 50% or 89% of the PLM neurons survived
in animals expressing gcn-1 or abcf-3, respectively, under the
control of the mec-7 promoter (Figure 5A). Expression of both
gcn-1 and abcf-3 also reduced a survival of the PLM neurons:
61% of the PLM neurons survived. These results indicate that
expression of gcn-1 and abcf-3 are sufficient to induce cell death
and suggest that gcn-1 and abcf-3 acts cell-autonomously to
promote programmed cell death.
Our genetic screen for mutants defective in M4 sister cell death
identified other genes in addition to gcn-1 and abcf-3: ceh-34, eya-
1, sptf-3 and pig-1 [15,17]. We previously showed that the Six
family homeodomain protein CEH-34 and the Eyes absent
homolog EYA-1 directly drive the transcription of the BH3-only
gene egl-1 in the M4 sister to promote M4 sister cell-type specific
Table 2. gcn-1(n4827) and abcf-3(n4927) enhance the M4 sister-cell death defect of ced-9(n2812) mutants.
Genotype1 % M4 sister survival
ced-3(n2446) 5
gcn-1(n4827); ced-3(n2446) 45
abcf-3(n4927); ced-3(n2446) 40
ced-9(n2812); ced-3(n2446) 50
gcn-1(n4827) ced-9(n2812); ced-3(n2446) 902
abcf-3(n4927) ced-9(n2812); ced-3(n2446) 892
1All strains were homozygous for nIs177[Pceh-28::gfp].
2Fisher’s exact test compared with ced-9(n2812), P,0.0001.
120 animals were scored for survival of the M4 sister.
doi:10.1371/journal.pgen.1004512.t002
Figure 5. GCN-1 and ABCF-3 act cell-autonomously in a
pathway distinct from the canonical cell-death execution
pathway. (A) The percentages of PLM survival in animals of the
indicated genotypes. All strains had the Pmec-4::gfp transgene that
expressed GFP in the touch neurons, including the PLM neurons. (B) A
model for the pathways that regulate M4 sister cell-specific pro-
grammed cell death. gcn-1 and abcf-3 act in a pathway distinct from the
canonical ced-9-dependent cell-death execution pathway to promote
M4 sister cell death. See text for details.
doi:10.1371/journal.pgen.1004512.g005
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death [15] and that the SP1 family transcription factor SPTF-3
directly drives the transcription of both egl-1 and the AMPK-
related protein kinase gene pig-1, which also promotes M4 sister
cell death [17]. We determined how gcn-1 and abcf-3 interact
with these genes by examining double mutants. The partial loss-of-
function alleles ceh-34(n4796) and sptf-3(n4850) and the null
allele pig-1(gm344D) enhanced the M4 sister-cell death defect of
gcn-1(n4827) and abcf-3(n4927) null mutants (Table 3). These
results indicate that ceh-34, sptf-3 and pig-1 function in pathways
distinct from that of gcn-1 and abcf-3 to promote M4 sister cell
death.
Discussion
The maternally-contributed translational regulators GCN-
1 and ABCF-3 act together to promote the death of the
M4 sister in a pathway distinct from the CED-9-mediated
cell-death execution pathway
We demonstrated that the translational regulators GCN-1 and
ABCF-3 are pro-apoptotic factors that maternally contribute to
the programmed cell death of the M4 sister in C. elegans. GCN-1
and ABCF-3 promote the deaths of all somatic cells tested.
Essentially all somatic cell deaths are mediated by an evolution-
arily conserved cell-death execution pathway consisting of the
BH3-only gene egl-1, the BCL-2 homolog ced-9, the APAF-1
homolog ced-4 and the caspase gene ced-3 [40]. How do gcn-1
and abcf-3 interact with this pathway to regulate apoptosis? We
propose that gcn-1 and abcf-3 likely act in a novel pathway distinct
from the canonical cell-death execution pathway. First, gcn-1 and
abcf-3 promote apoptosis in the absence of ced-9 activity,
indicating that gcn-1 and abcf-3 function independently of ced-9
in the regulation of apoptosis and hence do not regulate either ced-
9 or egl-1. Second since ced-3 and ced-4 function downstream of
ced-9 in the cell-death execution pathway, gcn-1 and abcf-3 could
act through these genes to promote cell death. However, our
mRNA-seq and Ribo-seq results indicate that gcn-1 and abcf-3 do
not have major effects on mRNA abundance or the ribosome
footprint density of ced-3 and ced-4 (Figure S6). Our preferred
model is that GCN-1 and ABCF-3 function in a pathway that acts
in parallel to the canonical cell-death execution pathway, although
we cannot preclude the possibility that GCN-1 and ABCF-3
translationally regulate unidentified factors that act through ced-3
or ced-4 without changing the transcriptional and translational
levels of the products of these genes. Also, since we used whole
animals for our mRNA-seq and Ribo-seq analyses, we would not
have detected alterations in CED-3 or CED-4 levels that were
specific to a small subset of cells, including the M4 sister.
Our genetic analyses revealed that gcn-1 and abcf-3 maternally
contribute to the death of the M4 sister, which undergoes
programmed cell death during embryogenesis. Maternally-con-
tributed factors might act to ensure the rapid deaths of cells during
embryogenesis; perhaps zygotic expression of apoptotic genes
would be too slow. Also, the maternal effects of gcn-1 and abcf-3
might explain why we discovered new general cell-death genes,
despite the fact that many genetic screens have been performed in
search of C. elegans mutants defective in somatic cell deaths. Most
such genetic screens have examined F2 animals after mutagenesis,
and would have missed maternally-contributed genes that affect
general cell death. Perhaps, additional maternal-effect genes with
functions in apoptosis exist in C. elegans. Such genes might be
efficiently identified by screening in the third generation after
mutagenesis.
gcn-1(n4827) and abcf-3(n4927) single mutations appeared to
cause a defect in only M4 sister cell death, and these mutations
both affected other cell deaths to differing extents in strains
sensitized to weak defects in cell death. For example, the death of
the M4 sister was most sensitive and the deaths of the PVQ sisters
were least sensitive to the gcn-1(n4827) and abcf-3(n4927)
mutations among the cells we tested (Table 1). We speculate that
sensitivity to perturbation of cell-death genes is different among
different cell types. This hypothesis is supported by the observa-
tions that penetrance of cell-death defects varies among different
cell types in partial loss-of-function ced-3(n2427) mutants and that
the extent of the cell-death defect of ced-3(n2427) mutants is well
correlated with that of gcn-1(n4827) and abcf-3(n4927) mutants.
Our genetic and biochemical data strongly suggest that GCN-1
and ABCF-3 physically interact in a complex in vivo to promote
apoptosis. First, GCN-1 and ABCF-3 interacted in the yeast two-
hybrid system. Second, GCN-1 co-immunoprecipitated with
ABCF-3 from a total protein extract from C. elegans. Third, the
absence of either the GCN-1 or ABCF-3 protein decreased the
steady-state level of the other protein (ABCF-3 or GCN-1,
respectively), indicating that an interaction between GCN-1 and
ABCF-3 is likely important for the stability of both proteins.
Fourth, gcn-1(n4827) abcf-3(n4927) double mutants were not
enhanced in the defect in apoptosis compared to each single
mutant.
GCN-1 and ABCF-3 play an essential role in germ-cell
death in response to ionizing radiation
Although GCN-1 and ABCF-3 promote the deaths of most
somatic cells, in gcn-1 or abcf-3 mutants only 12% or 13% of
animals are defective in M4 sister cell death, respectively, and the
cell-death defect of most other cells was observed only in a partial
loss-of-function ced-3 mutant background, which is sensitized to
weak defects in cell death. Furthermore, loss-of-function of gcn-1
and abcf-3 did not affect the deaths of germ cells under
physiological conditions. By striking contrast, we found that
GCN-1 and ABCF-3 play an essential role in germ-cell deaths
Table 3. ceh-34, eya-1, sptf-3 and pig-1 function
independently of gcn-1 and abcf-3.
Genotype
% M4 sister
survival
Wild-type 0
gnc-1(n4827) 12
abcf-3(n4927) 13
ceh-34(n4796) 382
sptf-3(n4850) 34
pig-1(gm344D) 20
gnc-1(n4827); ceh-34(n4796)1 523
gnc-1(n4827); sptf-3(n4850) 564
gnc-1(n4827); pig-1(gm344D) 685
abcf-3(n4927); ceh-34(n4796)1 543
abcf-3(n4927); sptf-3(n4850) 584
abcf-3(n4927); pig-1(gm344D) 635
1These strains were homozygous for unc-45(r450).
2Data from ref. 15.
3Fisher’s exact test compared with ceh-34(n4796), P,0.05.
4Fisher’s exact test compared with sptf-3(n4850), P,0.001.
5Fisher’s exact test compared with pig-1(gm344D), P,0.0001.
More than 120 animals were scored for survival of the M4 sister.
doi:10.1371/journal.pgen.1004512.t003
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induced by ionizing radiation. These results suggest that transla-
tional control by GCN-1 and ABCF-3 plays a more important role
in germ-cell deaths induced by ionizing radiation than in somatic
cell deaths. The hypothesis that translational control is particularly
important for cell deaths induced by ionizing radiation is
supported by a recent report that a mutation in RNA polymerase
I (rpoa-2), which synthesizes ribosomal RNAs, causes a defect in
germ-cell deaths induced by ionizing radiation [43].
Ionizing radiation causes DNA double-strand breaks, which
lead to the progressive accumulation of mutations and chromo-
somal aberrations as damaged cells undergo division, resulting in
apoptosis and the demise of genetically damaged cells. In C.
elegans, ionizing radiation causes massive deaths of the germ cells
during the late pachytene stage of oocyte development in adult
gonads, resulting in the elimination of the damaged oocytes [39].
Germ-cell deaths induced by ionizing radiation specifically involve
activation of the p53 homolog CEP-1 by the DNA damage
response pathway and subsequent CEP-1- dependent transcrip-
tional induction of the BH3-only gene egl-1, which activates the
cell-death execution pathway regulated by CED-9 [44,45]. How
might GCN-1 and ABCF-3 interact with the known DNA-damage
response and cell-death execution pathways in the regulation of
germline cell deaths induced by ionizing radiation? Our genetic
results suggest that GCN-1 and ABCF-3 function independently of
CED-9, at least in the regulation of the death of the M4 sister cell.
We suggest that as is the case for somatic cell deaths, GCN-1 and
ABCF-3 function in a novel pathway independently of CED-9 in
regulating the germ-cell deaths induced by ionizing radiation.
Alternatively, if GCN-1 and ABCF-3 regulate germ-cell deaths
induced by ionizing radiation via a mechanism different from that
of somatic cell deaths, it is possible that GCN-1 and ABCF-3 act
through egl-1 and its target ced-9, since egl-1 is involved in
somatic programmed cell deaths and germ-cell deaths induced by
ionizing radiation but not in the stochastic germ-cell deaths that
occur under physiological conditions.
The functions of GCN-1 and ABCF-3 in the control of
translation are conserved between S. cerevisiae and C.
elegans
GCN-1 and ABCF-3 are conserved proteins from yeast to
humans. The C. elegans GCN-1 protein has 43% and 53%
similarities (23% and 32% identities) to the homologs of S.
cerevisiae and humans, respectively, and the C. elegans ABCF-3
proteins has 57% and 69% similarities (40% and 49% identities) to
the homologs of S. cerevisiae and humans, respectively (Fig-
ure 1H). The yeast GCN-1 homolog Gcn1p and ABCF-3
homolog Gcn20p are required to maintain the basal level of the
phosphorylation of eukaryotic initiation factor 2a (eIF2a) in the
physiological condition and to increase the phosphorylation of
eIF2a in response to amino-acid starvation. Gcn1p and Gcn20p
activate the serine-threonine protein kinase Gcn2p, which
phosphorylates an evolutionarily conserved serine residue of
eIF2a. The phosphorylation of eIF2a results in both the inhibition
of global translation and the translational activation of the GCN4
mRNA, which encodes a basic leucine zipper transcription factor.
Translation of GCN4 mRNA is regulated by four short upstream
open reading frames (uORFs) in the 59 UTR with start codons
that are out-of-frame with the main coding sequence and which
generally reduce translation from the main reading frame [46].
We speculate that the mechanistic roles of C. elegans GCN-1
and ABCF-3 in translational control are conserved between yeast
and C. elegans. First, the amino-acid sequences of GCN-1 and
ABCF-3 proteins are conserved between yeast and C. elegans,
particularly in functionally important domains (Figure 1H).
Second, the functions of GCN-1 and ABCF-3 can be substituted
with those of S. cerevisiae GCN1 and GCN20, respectively, for
the promotion of M4 sister cell death. Third, like their yeast
counterparts, C. elegans GCN-1 and ABCF-3 are required to
maintain the basal level of phosphorylation of eIF2a and
physically interact through an EF3-like domain-containing region
of GCN-1 and an N-terminal ABCF-3 domain [43]. Fourth, like
Gcn20p, the AAA domain ATPase activity of ABCF-3 is not
required for its function [32]. Fifth, the atf-5 gene, the C. elegans
homolog of S. cerevisiae GCN4, has two upstream ORFs that
have been shown to inhibit the translation of the atf-5 mRNA
[47].
A regulatory network involving transcription, translation
and protein phosphorylation specifies the death of the
M4 sister
We have shown that in addition to gcn-1 and abcf-3, ceh-34,
eya-1, sptf-3 and pig-1 function in M4 sister cell death [15,17]. We
previously reported that the Six family homeodomain protein
CEH-34 and the Eyes absent homolog EYA-1 physically interact
to directly drive expression of the pro-apoptotic BH3-only gene
egl-1 in the M4 sister, leading to the death of the M4 sister
(Figure 5B) [15]. We found that the SP1 family transcription
factor SPTF-3 directly drives the transcription of the gene egl-1,
which encodes a BH3-only protein that promotes apoptosis via the
CED-3 caspase-mediated canonical cell-death execution pathway
[17]. SPTF-3 also directly drives the transcription of the AMPK-
related gene pig-1, which encodes a protein kinase that functions
in a pathway in parallel to the CED-3-mediated canonical cell-
death execution pathway. These interactions are shown in
Figure 5B.
Our analyses indicate that gcn-1 and abcf-3 likely function in a
pathway that acts in parallel to those of pig-1, ceh-34 and sptf-3.
These results are consistent with a model in which GCN-1 and
ABCF-3 act independently of CED-9 to promote M4 sister cell
death. In short, we propose that the regulatory network for the
death of the M4 sister includes at least three different pathways
involving translation, transcription and protein phosphorylation
(Figure 5B). Each gene in this network (gcn-1, abcf-3, sptf-3, pig-
1, egl-1, ceh-34 and eya-1) has a human counterpart, some of
which are implicated in human diseases, including developmental
disorders and cancer. We anticipate that further analyses of this
regulatory network will both reveal an evolutionarily conserved
mechanism of apoptosis shared between C. elegans and humans
and provide insights concerning how abnormalities in this
apoptotic network can lead to human disease.
Materials and Methods
C. elegans strains
C. elegans strains were cultured at 20uC as described [48]. The
N2 strain was used as the wild type. The following mutations,
integrations and extrachromosomal arrays were used.
LGI: sptf-3(n4850), eya-1(ok654D), nIs177[Pceh-28::gfp, lin-
15AB(+)], nIs180[Ptdc-1::gfp, lin-15AB(+)], zdIs5[Pmec-4::gfp,
lin-15AB(+)].
LGII: rol-1(e91), gcn-2(ok871D), Y38E10A.8(tm4094D).
LGIII: ced-4(n1162), ced-9(n2812), gcn-1(n4827, nc40D),
abcf-3(n4927, ok2237D), unc-45(r450), dpy-18(e364), nIs176
[Pceh-28::gfp, lin-15AB(+)].
LGIV: ced-3(n717, n2427, n2446), pig-1(gm344D),
nIs175[Pceh-28::gfp, lin-15AB(+)].
LGV: egl-1(n1084 n3082), ceh-34(n4796), oyIs14[sra-6::gfp].
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LGX: lin-15(n765), pek-1(ok275D), nIs106[Plin-11::gfp, lin-
15AB(+)], nIs429[Pphat-5::gfp, lin-15AB(+)], bcIs24[Ptph-1::gfp,
lin-15AB(+)].
Unmapped: nIs460[Pgcn-1::gfp], nIs488[Pabcf-3::gfp], nIs645
and nIs646[Pmec-7::gcn-1 cDNA, Pmec-7::abcf-3 cDNA, Pmec-
3::mCherry, rol-6(su1006)], nIs648 and nIs649[Pmec-7::gcn-1
cDNA, Pmec-3::mCherry, rol-6(su1006)], nIs651 and nIs652[P-
mec-7::abcf-3 cDNA, Pmec-3::mCherry, rol-6(su1006)]. Extrachro-
mosomal arrays: nEx1817 and nEx1818[Pgcn-1::gcn-1
cDNA::gcn-1 39 UTR, Plin-44::gfp], nEx1925 and nEx1926[-
abcf-3(+), Plin-44::gfp], nEx1928 and nEx1929[abcf-3 K217M,
Plin-44::gfp], nEx1931 and nEx1932[abcf-3 K536M, Plin-
44::gfp], nEx1934 and nEx1935[abcf-3 K217M K536M, Plin-
44::gfp], nEx2223 and nEx2224[Pceh-34::eIF2a S49A, Plin-
44::gfp]
Genetic screen and mapping of gcn-1(n4827) and abcf-
3(n4927)
gcn-1(n4827) and abcf-3(n4927) were isolated from a genetic
screen for mutations that cause an extra GFP-positive M4-like cell
in animals carrying the Pceh-28::gfp transgene [15]. Mutagenesis
was performed as described [48]. Mutagenized P0 animals were
allowed to lay eggs, and 144,000 synchronized F2 animals were
screened with a fluorescence-equipped dissecting microscope.
Single nucleotide polymorphisms were used to map gcn-
1(n4827) and abcf-3(n4927) to a 175 kb interval (III:
2,044,521–2,220,200) and a 5.3 Mb interval (III: 5,346,407–
10,613,191), respectively [49]. Whole-genome sequencing of gcn-
1(n4827) mutants was performed using an Illumina/Solexa GAII,
according to the instructions of the manufacture. DNA sequencing
of the abcf-3 locus of abcf-3(n4927) mutants was performed using
an Applied Biosystems 31306.
Analyses of defects in programmed cell deaths of specific
cells
The programmed cell deaths of specific cells were scored at the
indicated stages using the following strains, which express GFP in
specific cells. A fluorescence-equipped compound microscope was
used to score the programmed cell deaths. M4 sister cell death,
nIs175, nIs176 or nIs177 at the L1 stage. g1A sister cell death,
nIs429 at the L1 stage. PVQ sister cell death, oyIs14 at the L4
stage [50]. NSM sister cell death, bcIs24 at the L1 stage [51]. RIM
and RIC sister cell death, nIs180 at the L1 stage. Extra cells in the
anterior pharynx were scored using a compound microscope
equipped with Nomarski differential interference contrast optics.
For physiological germ-cell deaths, germ-cell corpses in gonads of
animals 24 hours after the fourth-larval stage were counted by
direct observation using Nomarski optics. For ionizing radiation-
induced germ-cell deaths, fourth-larval stage animals were
exposed to 120 Gy of ionizing radiation, and germ-cell deaths
were scored using acridine orange at 24 hours post-irradiation as
described [38].
Plasmid construction
The transgenes Pceh-28::gfp, Ptph-1::gfp and sra-6::gfp are
described [15,50,51]. The phat-5 promoter sequence in pGD48
was cloned in pPD122.56 to generate the Pphat-5::gfp transgene
[52]. The Pflp-15::gfp transgene contained 2.4 kbp of the 59
promoter of flp-15 in pPD122.56. The Pgcy-37::gfp transgene
contained 1.1 kbp of 59 promoter of gcy-37 in pPD122.56. The
Ptdc-1::gfp transgene contained 4.5 kbp of 59 promoter of tdc-1 in
pPD121.83. The Pgcn-1::gcn-1 cDNA::gcn-1 39UTR transgene
(pTH gcn-1 cDNA) contained 4.2 kbp of 59 promoter of gcn-1, a
full-length gcn-1 cDNA and 1.0 kbp 39 of the stop codon of gcn-1.
The 59 promoter of gcn-1, a full-length gcn-1 cDNA and the 39
promoter of gcn-1 were generated by PCR and fused in
pBluescript II using the In-Fusion cloning system (Clontech).
The abcf-3(+) transgene contained 1.6 kbp of 59 promoter, the
coding region and 0.8 kbp 39 of the stop codon of abcf-3 in
pBluescript II. The QuickChange II XL Site-Directed Mutagen-
esis Kit (Stratagene) was used to generate transgenes of abcf-3
K217M, abcf-3 K536M and abcf-3 K217M K536M. gcn-1
cDNA corresponding to amino acids 1–2634, 1–1760, 1–880,
880–2634, 880–1760 or 1760–2634 of GCN-1 was cloned in
pGBKT7. abcf-3 cDNA corresponding to amino acids 1–712, 1–
512, 1–202, 202–712, 512–712 or 202–512 was cloned in
pGADT7. The Pgcn-1::gfp transgene contained 4.2 kbp of 59
promoter of gcn-1 in pPD122.56. The Pabcf-3::gfp transgene
contained 1.6 kbp of 59 promoter of abcf-3 in pPD122.56. The
Pceh-34::eIF2a S49A transgene contained 3.8 kbp of 59 promoter
of ceh-34 and eIF2a with a replacement of serine 49 with alanine
in pPD49.26. For the Pmec-7::gcn-1 cDNA and Pmec-7::abcf-3
cDNA transgenes, full-length cDNA of gcn-1 and abcf-3 were
cloned in pPD96.41. Primer sequences used are available from the
authors.
Germline transformation
Germline transformation was performed as described [53]. The
gfp reporter transgene was injected at 50 mg/ml into lin-
15(n765ts) animals with 50 mg/ml of pL15EK as a coinjection
marker [54]. To rescue the defect in M4 sister cell death, the
transgenes pTH gcn-1 cDNA, abcf-3(+), abcf-3 K217M, abcf-3
K536M and abcf-3 K217M K536M described above were
injected at 20 mg/ml into gcn-1(n4827) or abcf-3(n4927) animals
with 50 mg/ml of Plin-44::gfp as a coinjection marker [55]. To
establish transgenic lines carrying the Pceh-34::eIF2a S49A
transgene, the Pceh-34::eIF2a S49A transgene was injected at
50 mg/ml into nIs175 animals with 50 mg/ml of Plin-44::gfp as a
coinjection marker. The Pmec-7::gcn-1 cDNA and Pmec-7::abcf-3
cDNA transgenes were injected at 50 mg/ml, respectively, into
zdIs5 animals with 50 mg/ml of pRF4[rol-6(su1006)] and 20 mg/
ml of the Pmec-3::mCherry transgene as coinjection markers.
Yeast two-hybrid binding assay
GAL4 fusion constructs were introduced into yeast strain
PJ649A as described [56]. Single colonies were streaked and
cultured for two days at 30uC on SD plates containing minimal
supplements without tryptophan and leucine. Then yeast strains
were streaked and cultured for three days at 30uC on SD plates
containing minimal supplements without tryptophan, leucine and
histidine to test yeast growth.
Antibody production
Protein fragments corresponding to amino acids 753–857 of
GCN-1 and 74–185 of ABCF-3 fused to glutathione S- transferase
(GST) were expressed, purified using glutathione Sepharose 4B
(Amersham Biosciences) and used to raise rabbit anti-GCN-1 or
anti-ABCF-3 antibodies, respectively. Antisera were generated by
Pocono Rabbit Farm and Laboratory. Specific antibodies were
affinity-purified using identical GCN-1 or ABCF-3 protein
fragments fused to maltose-binding protein (MBP) and coupled
to Affigel 10 (Bio-Rad).
Western blots and immunoprecipitation analysis
Protein extracts were prepared from nIs175, gcn-1(n4827);
nIs175 and abcf-3(n4927); nIs175 animals synchronized at the
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fourth larval stage as described [57]. 10 mg of total protein was
loaded onto a 7.5% SDS PAGE gel and then transferred to
nitrocellulose membranes. The membranes were probed with anti-
GCN-1 or anti-ABCF-3 antibody. Immunocomplexes were
detected using HRP-conjugated anti-rabbit IgG secondary anti-
bodies (Invitrogen) followed by chemiluminescence (Western
Lightning ECL, PerkinElmer). To determine the level of
phosphorylated eIF2a, protein extracts were prepared from
nIs175, gcn-1(n4827); nIs175 and abcf-3(n4927); nIs175
animals synchronized at the fourth larval stage as described
[57]. 15 mg of total protein was loaded on a 10% SDS PAGE gel
and then transferred to nitrocellulose membranes. The mem-
branes were probed with anti-phospho-eIF2a (Cell Signaling
Technology) and anti-eIF2a antibodies [28]. Immunocomplexes
were detected as described above.
For immunoprecipitation experiments, protein extracts were
prepared from mixed-staged wild-type animals in TNE buffer
containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM
EDTA, 1% NP-40, 5 mM b-mercaptoethanol, 10% glycerol.
Protein extracts were mixed with either an affinity-purified anti-
ABCF-3 antibody or a control IgG at 4uC for 2 hours.
Immunocomplexes were recovered using Protein A Sepharose 4
Fast Flow (GE Healthcare Life Sciences) and washed with TNE
buffer four times. The recovered immunocomplexes were subject-
ed to western blot analysis using anti-GCN-1 or anti-ABCF-3
antibody.
Fluorescence in situ hybridization
Fluorescence in situ hybridization was performed as described
[58]. The gcn-1 and abcf-3 probes (Biosearch Technologies, Inc)
were conjugated to the fluorophore Cy5 using the Amersham Cy5
Mono-reactive Dye pack (GE Healthcare). DNA was visualized
using 49,6-diamidino-2-phenylindole (DAPI). The probe sequences
used are shown in Tables S3 and S4. Figures 4D and H are
maximum intensity projections of a Z-stack of images processed
with the FFT Bandpass Filter operations in the image processing
program Fiji. Oligonucleotides used for gcn-1 and abcf-3 FISH
probe were described in Table S6 and S7).
mRNA-seq and ribosome profiling (Ribo-seq)
For mRNA-seq [59], total RNA was purified using an RNAeasy
Mini kit (Qiagen) from synchronized L4 animals of wild-type
animals and gcn-1 and abcf-3 mutants. The purified RNA was
subjected to oligo (dT) selection, fragmentation and first- and
double-strand synthesis with an Illumina Tru-Seq kit according to
the manufacturer’s instructions. DNA fragments longer than
30 bp were purified using SPRI-TE beads (Beckmann Coulter)
according to the manufacturer’s instructions. The purified DNA
was end-repaired and single A bases were added for adaptor
ligations. The adaptor-ligated DNA was then subjected to double
SPRI-TE purification to select for 200 bp fragments. These
fragments were enriched and barcoded by PCR for multiplexing.
A final SPRI-TE purification was performed to purify the
barcoded RNA-Seq libraries for Illumina DNA sequencing using
HiSeq 2000. RNA-seq data were aligned against the C. elegans
reference genome (ce10) using the Burrows-Wheeler Aligner
(BWA) and Tophat.
Ribosome profiling was performed as described [60] with
modifications. Synchronized L4 wild type animals and gcn-1 and
abcf-3 mutants were collected and washed with M9 buffer three
times. Animals were homogenized using a dounce homogenizer in
lysis buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl,
5 mM MgSO4, 1 mM DTT, 100 mg/ml cycloheximide, 1%
Triton X-100 and 25 U/ml Turbo DNase (Invitrogen) and
centrifuged at 20,000 g for 20 min at 4uC. The absorbance of
the extract was measured at 260 nm. 40 absorbance units of
extract were incubated with 300 units of RNase I at 25uC for an
hour, and then 200 units of SUPERase In RNase Inhibitor
(Invitrogen) were added. Digested extracts were loaded on 10–
50% linear sucrose gradients containing 20 mM Tris (pH 7.5),
150 mM NaCl, 5 mM MgSO4, 1 mM DTT and 100 mg/ml
cycloheximide and centrifuged for three hours at 35, 000 rpm at
4uC using a SW-40 rotor to isolate a monosome fraction. RNA
from the monosome fraction was purified by phenol-chloroform
extraction followed by miRNeasy Mini Kit (Qiagen) and separated
using a 15% TBE-Urea gel (BioRad) to isolate ribosome-protected
fragments (RPFs). The RPFs were eluted from gels by incubating
in RNA elution buffer containing 300 mM sodium acetate
(pH 5.5), 1 mM EDTA and 0.25% SDS. RPFs were 39
dephosphorylated with T4 polynucleotide kinase (New England
Labs) and ligated to Universal miRNA Cloning Linker (New
England Labs) using T4 RNA ligase 2, truncated (New England
Labs) according to the manufacturer’s instructions. RPFs ligated
with the linker were separated from an unligated linker using a
15% TBE-Urea gel (BioRad) and eluted from gels using RNA
extraction buffer followed by phenol-chloroform extraction. RFPs
were reverse-transcribed by Superscript III (Invitrogen) with a
reverse transcription primer according to the manufacturer’s
instructions. The products of reverse transcripts (RT) were purified
using a 15% TBE-Urea gel (BioRad) and eluted from a gel by
incubating in DNA elution buffer containing 300 mM NaCl,
10 mM Tris (pH 8.0) and 1 mM EDTA followed by phenol-
chloroform extraction. The RT products were circularized by
CircLigase (Epicentre) according to the manufacturer’s instruc-
tions. About a quarter of the RT products were used in PCR
reactions containing 16 Phusion HF buffer, 0.2 mM dNTP,
0.5 mm forward library primer, 0.5 mm reverse indexed primer
and 0.02 units/ml Phusion polymerase (New England Labs), and
PCR was performed with a 30 second initial denaturation at
98uC, followed by 6, 8, 10, 12 and 14 cycles of 98uC for
10 second, 65uC for 10 second and 72uC for 5 second. PCR
products were separated using a 8% TBE gel (BioRad) and eluted
from gels by incubating in DNA elution buffer followed by phenol-
chloroform extraction. PCR products were suspended in 20 ml of
10 mM Tris (pH 8.0) and sequenced by HiSeq 2000. The adaptor
sequences (CTGTAGGCACCATC) from 39 end of the ribosome
footprint reads were removed, then trimmed reads were mapped
using BWA to distinguish the reads from ribosomal RNAs. About
60% of the reads were filtered out, and the remaining reads (non-
ribosomal) were aligned to the C. elegans reference genome (ce10)
using BWA and Tophat. Because translational initiation is thought
to be blocked rapidly by the stress animals encounter during
harvesting, many ribosomes are stalled at the beginning of each
transcript in the presence of cycloheximide, which prevents
translation elongation [34]. Hence, high frequencies of reads at
the beginning of each transcript might not correspond to high
rates of translation. For this reason, the reads that mapped to the
first 25 nucleotides of each transcript were not counted in
evaluating gene expression in the Ribo-seq analyses.
Supporting Information
Figure S1 Genomic positions of gcn-1 and abcf-3. (A) gcn-
1(n4827) mapped to a 175 kb interval between nucleotides
2,044,521 and 2,220,000 on chromosome III. Arrowheads,
mutations found by whole-genome sequencing within the interval.
Black arrowhead, mutation located in non-coding region. Red
arrowhead, n4827. Black bar, gcn-1 gene. Nucleotide numbers
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are genomic positions based on WormBase WS53. (B) abcf-
3(n4927) mapped to a 5.3 Mb interval between nucleotides
5,346,407 and 10,613,191 of chromosome III. The positions of the
abcf-3 and ced-9 loci are indicated.
(EPS)
Figure S2 Alignment of the C. elegans GCN-1 protein sequence
with those of yeast Gcn1p and human GCN1. The CLUSTAL W
algorithm was used to align the amino acid sequences. Identical
amino acids and similar amino acids are indicated with black
boxes and gray boxes, respectively. Red arrowhead, position of the
amino acid altered by n4827. Orange underline, EF3-like domain.
(EPS)
Figure S3 Alignment of C. elegans ABCF-3 protein sequence
with those of yeast Gcn20p and human ABCF3. The CLUSTAL W
algorithm was used to align the amino acids. Identical amino acids
and similar amino acids are indicated with black boxes and gray
boxes, respectively. Red arrowhead, position of the amino acid
altered by n4927. Green underline, extent of the AAA domains.
(EPS)
Figure S4 gcn-1 and abcf-3 affect the expression of similar sets of
genes. (A) Biplots showing log2-fold changes of rpkm (reads per
kilobase per million) in mRNA-seq (x-axis) and Ribo-seq (y axis)
between wild-type animals and gcn-1 mutants. (B) Biplots showing
log2-fold changes of rpkm in mRNA-seq (x-axis) and Ribo-seq (y
axis) between wild-type animals and abcf-3 mutants. (C and D)
Heatmap displaying genes with changes of rpkm in both gcn-1 and
abcf-3 mutants compared to wild-type animals (p,1025) in mRNA-
seq and Ribo-seq. Log2-fold changes in expression of these genes
were hierarchically clustered using a Euclidean distance metric. (E
and F) Venn diagram showing overlap of differentially-regulated
genes (.2 fold, p,0.1) in gcn-1 and abcf-3 mutants compared to
wild-type animals based on mRNA-seq or Ribo-seq analyses.
(EPS)
Figure S5 gcn-1 and abcf-3 do not affect germ-cell death in
physiological conditions. Number of apoptotic cell corpses in the
gonads of animals of the indicated genotypes at 24 hours after the
fourth-larval stage (L4) as visualized using Nomarski optics. Black
bars, means. Errors, standard deviations.
(EPS)
Figure S6 gcn-1 and abcf-3 do not have a major effect on the
translational efficiency of ced-3 and ced-4. Normalized reads
(rpkm) of ced-3, ced-4 and npr-4 in mRNA-seq and Ribo-seq
analyses are shown for wild-type animals and gcn-1 and abcf-3
mutants.
(EPS)
Table S1 mRNA-seq and ribosome profiling analyses of wild-
type animals and gcn-1 and abcf-3 mutants.
(XLSX)
Table S2 A list of genes for which transcription changes more
than two-fold in gcn-1 and abcf-3 mutants compared to the wild
type (p,0.1).
(XLSX)
Table S3 A list of genes for which translation changes more than
two-fold in gcn-1 and abcf-3 mutants compared to the wild type
(p,0.1).
(XLSX)
Table S4 Presumptive eIF2a kinases GCN-2, PEK-1 and
Y38E10A.8 do not affect the death of the M4 sister.
(DOCX)
Table S5 In controlling M4 sister cell death, gcn-1 and abcf-3
maternally contribute and genetically interact with genes in the
cell-death execution pathway.
(DOCX)
Table S6 Oligonucleotides used for gcn-1 FISH probe.
(DOCX)
Table S7 Oligonucleotides used for abcf-3 FISH probe.
(DOCX)
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